• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-肾上腺素能激动剂与骨骼肌肥大

Beta-adrenergic agonists and hypertrophy of skeletal muscles.

作者信息

Kim Y S, Sainz R D

机构信息

University of Hawaii, Manoa 96822.

出版信息

Life Sci. 1992;50(6):397-407. doi: 10.1016/0024-3205(92)90374-x.

DOI:10.1016/0024-3205(92)90374-x
PMID:1346465
Abstract

Chronic administration of some beta-adrenergic agonists markedly stimulates hypertrophy of skeletal muscles. It appears that type II fibers are more responsive to beta-adrenergic agonists than type I fibers. The hypertrophic effect of beta-adrenergic agonists is transient, with the effect diminishing during prolonged treatment. Similarly, some cellular responses including the increase in RNA concentration and the decrease in calpain I activity are also short-lived. Recent evidence suggests that the temporal response is associated with decreased beta-adrenoceptor density. Both increased rate of protein synthesis and/or decreased protein degradation have been suggested as the mechanism of action of these compounds on hypertrophy of skeletal muscles. It is important to consider the temporal nature of cellular responses to chronic treatment of beta-adrenergic agonists as well as the differential effects of these compounds on protein metabolism among skeletal muscle fiber types when investigating the mechanism(s) of action of these compounds.

摘要

长期施用某些β-肾上腺素能激动剂可显著刺激骨骼肌肥大。似乎II型纤维比I型纤维对β-肾上腺素能激动剂更敏感。β-肾上腺素能激动剂的肥大效应是短暂的,在长期治疗过程中效应会减弱。同样,一些细胞反应,包括RNA浓度的增加和钙蛋白酶I活性的降低,也是短暂的。最近的证据表明,这种时间反应与β-肾上腺素能受体密度降低有关。蛋白质合成速率增加和/或蛋白质降解减少都被认为是这些化合物对骨骼肌肥大作用的机制。在研究这些化合物的作用机制时,重要的是要考虑细胞对β-肾上腺素能激动剂长期治疗的时间反应特性,以及这些化合物对不同类型骨骼肌纤维蛋白质代谢的差异影响。

相似文献

1
Beta-adrenergic agonists and hypertrophy of skeletal muscles.β-肾上腺素能激动剂与骨骼肌肥大
Life Sci. 1992;50(6):397-407. doi: 10.1016/0024-3205(92)90374-x.
2
Changes in calpain and calpastatin mRNA induced by beta-adrenergic stimulation of bovine skeletal muscle.β-肾上腺素能刺激牛骨骼肌诱导的钙蛋白酶和钙蛋白酶抑制蛋白mRNA的变化
Eur J Biochem. 1992 Sep 1;208(2):333-9. doi: 10.1111/j.1432-1033.1992.tb17191.x.
3
Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic {beta}-adrenoceptor stimulation in mice.慢性β-肾上腺素受体刺激小鼠骨骼肌蛋白合成和分解的时间变化的细胞机制。
J Physiol. 2010 Dec 1;588(Pt 23):4811-23. doi: 10.1113/jphysiol.2010.196725. Epub 2010 Oct 11.
4
Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.对大鼠进行β2肾上腺素能受体激动剂福莫特罗和沙美特罗的全身给药,在微摩尔剂量下可引起骨骼肌肥大。
Br J Pharmacol. 2006 Mar;147(6):587-95. doi: 10.1038/sj.bjp.0706669.
5
Effect of the beta-adrenergic agonist L644,969 on muscle growth, endogenous proteinase activities, and postmortem proteolysis in wether lambs.β-肾上腺素能激动剂L644,969对去势羔羊肌肉生长、内源性蛋白酶活性及宰后蛋白水解的影响。
J Anim Sci. 1991 Dec;69(12):4823-35. doi: 10.2527/1991.69124823x.
6
A 31P-NMR study of the acute effects of altered beta-adrenoceptor stimulation on the bioenergetics of skeletal muscle during contraction.一项关于β-肾上腺素能受体刺激改变对收缩期间骨骼肌生物能量学急性影响的31P-核磁共振研究。
Biochem Pharmacol. 1988 Dec 15;37(24):4653-9. doi: 10.1016/0006-2952(88)90334-6.
7
Effect of beta-agonists on expression of calpain and calpastatin activity in skeletal muscle.
Biochimie. 1992 Mar;74(3):267-73. doi: 10.1016/0300-9084(92)90125-x.
8
Beta-adrenoceptors and the effect of beta-agonists on protein metabolism in ovine primary muscle cultures.
Biochem Pharmacol. 1990 Nov 15;40(10):2271-6. doi: 10.1016/0006-2952(90)90722-w.
9
Beta adrenoceptor interaction of full and partial agonists in the cat heart and soleus muscle.猫心脏和比目鱼肌中完全激动剂和部分激动剂的β肾上腺素能受体相互作用。
J Pharmacol Exp Ther. 1981 Dec;219(3):798-808.
10
Application of cellular mechanisms to growth and development of food producing animals.细胞机制在食用动物生长发育中的应用。
J Anim Sci. 2008 Apr;86(14 Suppl):E226-35. doi: 10.2527/jas.2007-0450. Epub 2007 Oct 26.

引用本文的文献

1
β-Adrenoceptors activation regulates muscle trophic-related genes following acute resistance exercise in mice.β-肾上腺素能受体激活可调节小鼠急性抗阻运动后与肌肉营养相关的基因。
Front Physiol. 2024 Jan 22;15:1268380. doi: 10.3389/fphys.2024.1268380. eCollection 2024.
2
Obliteration of the Processus Vaginalis After Testicular Descent.睾丸下降后鞘突消失。
Balkan Med J. 2024 Mar 1;41(2):89-96. doi: 10.4274/balkanmedj.galenos.2024.2023-12-111. Epub 2024 Jan 25.
3
Beta-Adrenergic Agonists, Dietary Protein, and Rumen Bacterial Community Interactions in Beef Cattle: A Review.
肉牛中β-肾上腺素能激动剂、膳食蛋白质与瘤胃细菌群落的相互作用:综述
Vet Sci. 2023 Sep 18;10(9):579. doi: 10.3390/vetsci10090579.
4
Pharmacological Treatments for Congenital Myasthenic Syndromes Caused by Mutations.先天性肌营养不良症致药物治疗突变。
Curr Neuropharmacol. 2023;21(7):1594-1605. doi: 10.2174/1570159X21666230126145652.
5
Muscle Stem Cell Function Is Impaired in β2-Adrenoceptor Knockout Mice.β2 肾上腺素能受体基因敲除小鼠的肌肉干细胞功能受损。
Stem Cell Rev Rep. 2022 Oct;18(7):2431-2443. doi: 10.1007/s12015-022-10334-y. Epub 2022 Mar 4.
6
Effects of Ferulic Acid Supplementation on Growth Performance, Carcass Traits and Histochemical Characteristics of Muscle Fibers in Finishing Pigs.阿魏酸添加对育肥猪生长性能、胴体性状及肌纤维组织化学特性的影响
Animals (Basel). 2021 Aug 20;11(8):2455. doi: 10.3390/ani11082455.
7
Transcriptome analysis reveals the long intergenic noncoding RNAs contributed to skeletal muscle differences between Yorkshire and Tibetan pig.转录组分析揭示了长基因间非编码 RNA 对约克夏猪和藏猪骨骼肌差异的贡献。
Sci Rep. 2021 Jan 29;11(1):2622. doi: 10.1038/s41598-021-82126-2.
8
Ractopamine-induced fiber type-specific gene expression in porcine skeletal muscles is independent of growth.莱克多巴胺诱导猪骨骼肌中纤维类型特异性基因表达与生长无关。
J Anim Sci. 2020 Nov 1;98(11). doi: 10.1093/jas/skaa341.
9
Sympatho-Vagal Imbalance is Associated with Sarcopenia in Male Patients with Heart Failure.交感神经-迷走神经失衡与男性心力衰竭患者的肌肉减少症有关。
Arq Bras Cardiol. 2019 Jun;112(6):739-746. doi: 10.5935/abc.20190061. Epub 2019 Apr 8.
10
Respiratory dysfunction following initiation of mirabegron: A case report.米拉贝隆起始治疗后出现的呼吸功能障碍:一例报告。
Respir Med Case Rep. 2019 Feb 16;26:304-306. doi: 10.1016/j.rmcr.2019.02.012. eCollection 2019.